Tokyo, Aug. 27 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058835) titled 'Validation of Dynamic SPECT Imaging Using the StarGuide Dedicated SPECT System' on Aug. 27.

Study Type: Interventional

Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Uncontrolled

Primary Sponsor: Institute - Tohoku University

Condition: Condition - Renal dysfunction Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To verify that dynamic SPECT imaging with the StarGuide dedicated SPECT system can reproduce the examinations conventionally performed with renal scintigraphy. Basic objectives2 - Others

Intervention: Interventions/Control_1 - Patients who have undergone conventional renal scintigraphy will additionally undergo dynamic imaging using the dedicated SPECT system StarGuide with 99mTc-DTPA or 99mTc-MAG3, in order to confirm the feasibility of acquiring dynamic renal SPECT images. The radiopharmaceutical and imaging protocol for renal scintigraphy will be the same as those conventionally used. Clinical examinations of the patient will be conducted both before and after administration.

Eligibility: Age-lower limit - 20 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - Patients who have provided written informed consent to participate in this study Patients scheduled to undergo, or who have undergone, renal scintigraphy with 99mTc-DTPA or 99mTc-MAG3 for clinical renal function assessment Adults aged 20 years or older Individuals judged eligible for participation by the principal investigator or sub-investigator Key exclusion criteria - Patients who are pregnant or potentially pregnant Patients who are expected to have difficulty remaining still during imaging Patients whom the principal investigator judges to be inappropriate for participation in this study (e.g., when any therapeutic intervention for the kidneys has been performed between the initial renal scintigraphy and the imaging in this study) Target Size - 10

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2025 Year 08 Month 19 Day Anticipated trial start date - 2025 Year 08 Month 27 Day Last follow-up date - 2026 Year 07 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067279

Disclaimer: Curated by HT Syndication.